- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01862393
Stimulus Phase Duration on Discomfort and Electrically Induced Torque of Quadriceps Femoris
August 31, 2016 updated by: Richard Eloin Liebano, Universidade Cidade de Sao Paulo
The Influence of Stimulus Phase Duration on Discomfort and Electrically Induced Torque of Quadriceps Femoris
This study aims to examine the variation in muscle torque and discomfort produced when electrically stimulating quadriceps femoris using pulsed current with three different phase durations in order to establish whether there are any advantages or disadvantages in varying the phase duration over the range examined.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
Sao Paulo, SP, Brazil, 03071-000
- Universidade Cidade de Sao Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- sedentary healthy university students.
Exclusion Criteria:
- history of knee surgery or injury,
- musculoskeletal, cardiovascular or neurological disease including impaired sensation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 400 microseconds
Electrically-induced torque generated with stimulus phase duration set at 400 microseconds.
|
Neuromuscular electrical stimulation with stimulus phase duration of 400 microseconds
|
|
Experimental: 700 microseconds
Electrically-induced torque generated with stimulus phase duration set at 700 microseconds.
|
Neuromuscular electrical stimulation with stimulus phase duration of 700 microseconds
|
|
Experimental: 1000 microseconds
Electrically-induced torque generated with stimulus phase duration set at 1000 microseconds.
|
Neuromuscular electrical stimulation with stimulus phase duration of 1000 microseconds
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Torque
Time Frame: During 4 seconds of electrical stimulation
|
Torque will be measured using an isokinetic dynamometer.
Torque will be registered in Newton meter [N.m]
|
During 4 seconds of electrical stimulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Discomfort
Time Frame: During 6 seconds of electrical stimulation
|
Discomfort will be measured using a 10 cm visual analogue scale (VAS) ranging from zero (no discomfort) to 10 (worst discomfort imaginable).
|
During 6 seconds of electrical stimulation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Richard E Liebano, PhD, Universidade Cidade de Sao Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (Actual)
December 1, 2008
Study Completion (Actual)
December 1, 2008
Study Registration Dates
First Submitted
May 17, 2013
First Submitted That Met QC Criteria
May 21, 2013
First Posted (Estimate)
May 24, 2013
Study Record Updates
Last Update Posted (Estimate)
September 1, 2016
Last Update Submitted That Met QC Criteria
August 31, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CAAE - 0081.0.186.000-07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Perception
-
Mouetaz KheirallahActive, not recruiting
-
Shatha Musaad AlharthiNot yet recruiting
-
Medical University of ViennaRecruitingTransgender Persons | Pain Threshold | Sex Hormones | Perception of PainAustria
-
Cairo UniversityNot yet recruitingPain Perception of the New Device
-
King Abdulaziz UniversityCompletedPain Perception of the New DeviceSaudi Arabia
-
Universidad Autonoma de San Luis PotosíCompletedPain Perception | Topical Anesthesia | Local Anesthetic InfiltrationMexico
-
Stéphane PotvinCompleted
-
Aga Khan University Hospital, PakistanCompleted
-
University of GiessenCompletedPain PerceptionGermany
-
University of OklahomaWithdrawnPain Perception | PhlebotomyUnited States
Clinical Trials on 400 microseconds
-
University of MiamiCompletedCicatrix | ScarsUnited States
-
Nanjing Nutrabuilding Bio-tech Co., Ltd.Biofortis, Merieux NutriSciencesRecruiting
-
Dr. Reddy's Laboratories LimitedXenoPort, Inc.Completed
-
Vantive Health LLCBaxter Healthcare Corporation; German Federal Ministry of Education and Research and other collaboratorsCompleted
-
Penumbra Inc.TerminatedIntracranial AneurysmsUnited States
-
CAGE Bio Inc.ethica Clinical Research Inc.Completed
-
CAGE Bio Inc.ethica Clinical Research Inc.Completed
-
Vantive Health LLCBaxter Healthcare CorporationCompletedEnd Stage Renal DiseaseAustria
-
ivWatch, LLCNot yet recruitingInfiltration of Peripheral IV Therapy
-
University of KragujevacPharmanova d.o.o., Obrenovac, SerbiaTerminatedAnemia | Renal Disease | Dialysis; ComplicationsSerbia